Principal Investigator
Warren Alperstein
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20221388
Clinical Trial Summary
Phase I/II trial: Engineered Donor Graft (Orca-Q) for Pediatric Hematopoietic Cell Transplant (HCT) Recipients with Hematologic Malignancies (HM)
Phase
Phase I/II
Funding Agency/Sponsor
Institutional
Disease
Pediatric Cancer
Contact Information
Phone Number
305-243-2647